2,905 Shares in Colgate-Palmolive Company $CL Purchased by Monument Capital Management

Monument Capital Management purchased a new stake in Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,905 shares of the company’s stock, valued at approximately $264,000.

A number of other large investors have also recently modified their holdings of the business. Commerzbank Aktiengesellschaft FI raised its stake in Colgate-Palmolive by 7.8% in the second quarter. Commerzbank Aktiengesellschaft FI now owns 27,837 shares of the company’s stock valued at $2,530,000 after purchasing an additional 2,015 shares in the last quarter. Callan Family Office LLC raised its position in shares of Colgate-Palmolive by 286.3% during the 2nd quarter. Callan Family Office LLC now owns 18,685 shares of the company’s stock valued at $1,698,000 after buying an additional 13,848 shares in the last quarter. Leo Wealth LLC raised its position in shares of Colgate-Palmolive by 71.2% during the 2nd quarter. Leo Wealth LLC now owns 15,945 shares of the company’s stock valued at $1,449,000 after buying an additional 6,632 shares in the last quarter. Armstrong Fleming & Moore Inc bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $271,000. Finally, Maryland State Retirement & Pension System increased its stake in Colgate-Palmolive by 2.8% in the second quarter. Maryland State Retirement & Pension System now owns 39,075 shares of the company’s stock valued at $3,552,000 after acquiring an additional 1,076 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.2%

NYSE CL opened at $77.99 on Friday. Colgate-Palmolive Company has a 1-year low of $77.09 and a 1-year high of $102.61. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a 50-day moving average of $82.56 and a 200-day moving average of $87.91. The firm has a market cap of $63.03 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 4.28 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the previous year, the company posted $0.91 EPS. Colgate-Palmolive’s revenue for the quarter was up 1.0% on a year-over-year basis. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s payout ratio is 58.43%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on CL shares. Citigroup dropped their price target on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research note on Monday, August 4th. The Goldman Sachs Group dropped their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, October 2nd. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a research note on Thursday, September 25th. Barclays lowered their price objective on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Finally, Piper Sandler initiated coverage on shares of Colgate-Palmolive in a report on Friday, October 3rd. They set a “neutral” rating and a $84.00 target price on the stock. Eight research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $92.21.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.